Carteolol
Carteolol Brand names, Carteolol Analogs
Carteolol Brand Names Mixture
- No information avaliable
Carteolol Chemical_Formula
C16H24N2O3
Carteolol RX_link
http://www.rxlist.com/cgi/generic2/carteol.htm
Carteolol fda sheet
Carteolol msds (material safety sheet)
Carteolol Synthesis Reference
No information avaliable
Carteolol Molecular Weight
292.373 g/mol
Carteolol Melting Point
No information avaliable
Carteolol H2O Solubility
No information avaliable
Carteolol State
Solid
Carteolol LogP
2.037
Carteolol Dosage Forms
Ophthalmic Solution (1%)
Carteolol Indication
For the treatment of intraocular hypertension and chronic open-angle glaucoma
Carteolol Pharmacology
Carteolol is a beta1 and beta2 (non-selective) adrenergic receptor-blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anesthetic (membrane-stabilizing) activity. Carteolol, when applied topically to the eye, has the action of reducing elevated, as well as normal, intraocular pressure, whether or not accompanied by glaucoma. Elevated intraocular pressure is a major risk factor in the pathogenesis of glaucomatous visual field loss and optic nerve damage. Carteolol reduces intraocular pressure with little or no effect on pupil size or accommodation in contrast to the miosis which cholinergic agents are known to produce.
Carteolol Absorption
No information avaliable
Carteolol side effects and Toxicity
The most common effects expected with overdosage of a beta-adrenergic blocking agent are bradycardia, bronchospasm, congestive heart failure and hypotension.
Carteolol Patient Information
No information avaliable
Carteolol Organisms Affected
Humans and other mammals
